Co-Authors
This is a "connection" page, showing publications co-authored by AYUMU TAGUCHI and ZIDING FENG.
Connection Strength
0.882
-
Failure to Disclose Potential Conflict of Interest-Letter of Explanation. JAMA Oncol. 2019 12 01; 5(12):1811.
Score: 0.175
-
A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data. Biometrics. 2017 03; 73(1):42-51.
Score: 0.138
-
MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Cancer Prev Res (Phila). 2015 Nov; 8(11):1112-9.
Score: 0.131
-
Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. J Clin Oncol. 2015 Nov 20; 33(33):3880-6.
Score: 0.130
-
Pro-surfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol. 2013 Dec 20; 31(36):4536-43.
Score: 0.115
-
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2019 04 01; 111(4):372-379.
Score: 0.042
-
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun. 2019 01 16; 10(1):254.
Score: 0.041
-
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins. JAMA Oncol. 2018 10 01; 4(10):e182078.
Score: 0.040
-
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017 04 01; 109(4).
Score: 0.036
-
Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer. Cancer Prev Res (Phila). 2016 Apr; 9(4):317-23.
Score: 0.034